These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 11923290

  • 1. Targeted expression of a protease-resistant IGFBP-4 mutant in smooth muscle of transgenic mice results in IGFBP-4 stabilization and smooth muscle hypotrophy.
    Zhang M, Smith EP, Kuroda H, Banach W, Chernausek SD, Fagin JA.
    J Biol Chem; 2002 Jun 14; 277(24):21285-90. PubMed ID: 11923290
    [Abstract] [Full Text] [Related]

  • 2. Overexpression of insulin-like growth factor-binding protein-4 (IGFBP-4) in smooth muscle cells of transgenic mice through a smooth muscle alpha-actin-IGFBP-4 fusion gene induces smooth muscle hypoplasia.
    Wang J, Niu W, Witte DP, Chernausek SD, Nikiforov YE, Clemens TL, Sharifi B, Strauch AR, Fagin JA.
    Endocrinology; 1998 May 14; 139(5):2605-14. PubMed ID: 9564877
    [Abstract] [Full Text] [Related]

  • 3. Targeted overexpression of IGF-I evokes distinct patterns of organ remodeling in smooth muscle cell tissue beds of transgenic mice.
    Wang J, Niu W, Nikiforov Y, Naito S, Chernausek S, Witte D, LeRoith D, Strauch A, Fagin JA.
    J Clin Invest; 1997 Sep 15; 100(6):1425-39. PubMed ID: 9294108
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Paracrine overexpression of IGFBP-4 in osteoblasts of transgenic mice decreases bone turnover and causes global growth retardation.
    Zhang M, Faugere MC, Malluche H, Rosen CJ, Chernausek SD, Clemens TL.
    J Bone Miner Res; 2003 May 15; 18(5):836-43. PubMed ID: 12733722
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The alpha-smooth muscle actin promoter: a useful tool to analyse autocrine and paracrine roles of mesenchymal cells in normal and diseased bowel.
    Lund PK.
    Gut; 1998 Mar 15; 42(3):320-2. PubMed ID: 9577334
    [Abstract] [Full Text] [Related]

  • 9. Insulin-like growth factors stimulate the release of insulin-like growth factor-binding protein-3 (IGFBP-3) and degradation of IGFBP-4 in nonsmall cell lung cancer cell lines.
    Noll K, Wegmann BR, Havemann K, Jaques G.
    J Clin Endocrinol Metab; 1996 Jul 15; 81(7):2653-62. PubMed ID: 8675593
    [Abstract] [Full Text] [Related]

  • 10. Protease-resistant insulin-like growth factor (IGF)-binding protein-4 inhibits IGF-I actions and neointimal expansion in a porcine model of neointimal hyperplasia.
    Nichols TC, Busby WH, Merricks E, Sipos J, Rowland M, Sitko K, Clemmons DR.
    Endocrinology; 2007 Oct 15; 148(10):5002-10. PubMed ID: 17640990
    [Abstract] [Full Text] [Related]

  • 11. Overexpression of gly56/gly80/gly81-mutant insulin-like growth factor-binding protein-3 in transgenic mice.
    Silha JV, Gui Y, Mishra S, Leckstrom A, Cohen P, Murphy LJ.
    Endocrinology; 2005 Mar 15; 146(3):1523-31. PubMed ID: 15550509
    [Abstract] [Full Text] [Related]

  • 12. IGF-I differentially regulates IGF-binding protein expression in primary mammary fibroblasts and epithelial cells.
    Fleming JM, Leibowitz BJ, Kerr DE, Cohick WS.
    J Endocrinol; 2005 Jul 15; 186(1):165-78. PubMed ID: 16002546
    [Abstract] [Full Text] [Related]

  • 13. Vascular smooth muscle cells synthesize two forms of insulin-like growth factor binding proteins which are regulated differently by the insulin-like growth factors.
    Cohick WS, Gockerman A, Clemmons DR.
    J Cell Physiol; 1993 Oct 15; 157(1):52-60. PubMed ID: 7691836
    [Abstract] [Full Text] [Related]

  • 14. Expression and insulin-like growth factor-dependent proteolysis of insulin-like growth factor-binding protein-4 are regulated by cell confluence in vascular smooth muscle cells.
    Kamyar A, Pirola CJ, Wang HM, Sharifi B, Mohan S, Forrester JS, Fagin JA.
    Circ Res; 1994 Apr 15; 74(4):576-85. PubMed ID: 7511071
    [Abstract] [Full Text] [Related]

  • 15. Evidence that the interaction between insulin-like growth factor (IGF)-II and IGF binding protein (IGFBP)-4 is essential for the action of the IGF-II-dependent IGFBP-4 protease.
    Qin X, Byun D, Lau KH, Baylink DJ, Mohan S.
    Arch Biochem Biophys; 2000 Jul 15; 379(2):209-16. PubMed ID: 10898936
    [Abstract] [Full Text] [Related]

  • 16. Heparin-binding EGF-like growth factor (HB-EGF) overexpression in transgenic mice downregulates insulin-like growth factor binding protein (IGFBP)-3 and -4 mRNA.
    Provenzano AP, Besner GE, James PF, Harding PA.
    Growth Factors; 2005 Mar 15; 23(1):19-31. PubMed ID: 16019424
    [Abstract] [Full Text] [Related]

  • 17. Testes-specific transgene expression in insulin-like growth factor-I transgenic mice.
    Dyck MK, Ouellet M, Gagn M, Petitclerc D, Sirard MA, Pothier F.
    Mol Reprod Dev; 1999 Sep 15; 54(1):32-42. PubMed ID: 10423295
    [Abstract] [Full Text] [Related]

  • 18. Targeted disruption of the pregnancy-associated plasma protein-A gene is associated with diminished smooth muscle cell response to insulin-like growth factor-I and resistance to neointimal hyperplasia after vascular injury.
    Resch ZT, Simari RD, Conover CA.
    Endocrinology; 2006 Dec 15; 147(12):5634-40. PubMed ID: 16959843
    [Abstract] [Full Text] [Related]

  • 19. Smooth muscle-targeted overexpression of insulin-like growth factor I results in enhanced vascular contractility.
    Zhao G, Sutliff RL, Weber CS, Wang J, Lorenz J, Paul RJ, Fagin JA.
    Endocrinology; 2001 Feb 15; 142(2):623-32. PubMed ID: 11159833
    [Abstract] [Full Text] [Related]

  • 20. Cellular localization and sex steroid regulation of insulin-like growth factor binding protein messenger ribonucleic acids in the primate myometrium.
    Adesanya OO, Zhou J, Bondy CA.
    J Clin Endocrinol Metab; 1996 Jul 15; 81(7):2495-501. PubMed ID: 8675566
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.